Literature DB >> 19147903

Neutron production from beam-modifying devices in a modern double scattering proton therapy beam delivery system.

Angélica Pérez-Andújar1, Wayne D Newhauser, Paul M Deluca.   

Abstract

In this work the neutron production in a passive beam delivery system was investigated. Secondary particles including neutrons are created as the proton beam interacts with beam shaping devices in the treatment head. Stray neutron exposure to the whole body may increase the risk that the patient develops a radiogenic cancer years or decades after radiotherapy. We simulated a passive proton beam delivery system with double scattering technology to determine the neutron production and energy distribution at 200 MeV proton energy. Specifically, we studied the neutron absorbed dose per therapeutic absorbed dose, the neutron absorbed dose per source particle and the neutron energy spectrum at various locations around the nozzle. We also investigated the neutron production along the nozzle's central axis. The absorbed doses and neutron spectra were simulated with the MCNPX Monte Carlo code. The simulations revealed that the range modulation wheel (RMW) is the most intense neutron source of any of the beam spreading devices within the nozzle. This finding suggests that it may be helpful to refine the design of the RMW assembly, e.g., by adding local shielding, to suppress neutron-induced damage to components in the nozzle and to reduce the shielding thickness of the treatment vault. The simulations also revealed that the neutron dose to the patient is predominated by neutrons produced in the field defining collimator assembly, located just upstream of the patient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147903      PMCID: PMC4136452          DOI: 10.1088/0031-9155/54/4/012

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  23 in total

1.  Neutron shielding calculations in a proton therapy facility based on Monte Carlo simulations and analytical models: criterion for selecting the method of choice.

Authors:  U Titt; W D Newhauser
Journal:  Radiat Prot Dosimetry       Date:  2005       Impact factor: 0.972

2.  Virtual commissioning of a treatment planning system for proton therapy of ocular cancers.

Authors:  N Koch; W Newhauser
Journal:  Radiat Prot Dosimetry       Date:  2005       Impact factor: 0.972

Review 3.  Proton therapy in clinical practice: current clinical evidence.

Authors:  Michael Brada; Madelon Pijls-Johannesma; Dirk De Ruysscher
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

4.  Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm.

Authors:  Wayne Newhauser; Jonas Fontenot; Yuanshui Zheng; Jerimy Polf; Uwe Titt; Nicholas Koch; Xiaodong Zhang; Radhe Mohan
Journal:  Phys Med Biol       Date:  2007-07-10       Impact factor: 3.609

Review 5.  A review of proton beam radiation therapy.

Authors:  D W Miller
Journal:  Med Phys       Date:  1995-11       Impact factor: 4.071

6.  Monte Carlo simulation of a protontherapy platform devoted to ocular melanoma.

Authors:  J Hérault; N Iborra; B Serrano; P Chauvel
Journal:  Med Phys       Date:  2005-04       Impact factor: 4.071

7.  Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer.

Authors:  Phillip J Taddei; Jonas D Fontenot; Yuanshui Zheng; Dragan Mirkovic; Andrew K Lee; Uwe Titt; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2008-03-27       Impact factor: 3.609

8.  Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.

Authors:  Evangelos S Gragoudas; Anne Marie Lane; John Munzenrider; Kathleen M Egan; Wenjun Li
Journal:  Trans Am Ophthalmol Soc       Date:  2002

9.  Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit.

Authors:  Yuanshui Zheng; Jonas Fontenot; Phil Taddei; Dragan Mirkovic; Wayne Newhauser
Journal:  Phys Med Biol       Date:  2007-12-19       Impact factor: 3.609

Review 10.  A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer.

Authors:  Mark Lodge; Madelon Pijls-Johannesma; Lisa Stirk; Alastair J Munro; Dirk De Ruysscher; Tom Jefferson
Journal:  Radiother Oncol       Date:  2007-05-14       Impact factor: 6.280

View more
  19 in total

1.  An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy.

Authors:  Rui Zhang; Angélica Pérez-Andújar; Jonas D Fontenot; Phillip J Taddei; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Contribution to Neutron Fluence and Neutron Absorbed Dose from Double Scattering Proton Therapy System Components.

Authors:  A Pérez-Andújar; W D Newhauser; P M Deluca
Journal:  Nucl Technol       Date:  2009-01-01

3.  Monte Carlo and analytical model predictions of leakage neutron exposures from passively scattered proton therapy.

Authors:  Angélica Pérez-Andújar; Rui Zhang; Wayne Newhauser
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

4.  Technical Note: Optimization of spot and trimmer position during dynamically collimated proton therapy.

Authors:  Blake R Smith; Daniel E Hyer; Ryan T Flynn; Wesley S Culberson
Journal:  Med Phys       Date:  2019-03-05       Impact factor: 4.071

5.  Evaluation of energy deposition and secondary particle production in proton therapy of brain using a slab head phantom.

Authors:  Sayyed Bijan Jia; Mohammad Hadi Hadizadeh; Ali Asghar Mowlavi; Mahdy Ebrahimi Loushab
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-01

6.  Microdosimetric measurements for neutron-absorbed dose determination during proton therapy.

Authors:  Angélica Pérez-Andújar; Paul M Deluca; Allan F Thornton; Markus Fitzek; Draik Hecksel; Jonathan Farr
Journal:  Radiat Prot Dosimetry       Date:  2012-02-14       Impact factor: 0.972

Review 7.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

8.  Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator.

Authors:  David J Brenner; Carl D Elliston; Eric J Hall; Harald Paganetti
Journal:  Phys Med Biol       Date:  2009-09-24       Impact factor: 3.609

9.  The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation.

Authors:  A Pérez-Andújar; W D Newhauser; P J Taddei; A Mahajan; R M Howell
Journal:  Phys Med Biol       Date:  2013-04-19       Impact factor: 3.609

10.  Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer.

Authors:  Enzhuo M Quan; Wei Liu; Richard Wu; Yupeng Li; Steven J Frank; Xiaodong Zhang; X Ronald Zhu; Radhe Mohan
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.